These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 160)

  • 41. Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome.
    Kluger J; Drayer DE; Reidenberg MM; Lahita R
    Ann Intern Med; 1981 Jul; 95(1):18-23. PubMed ID: 6166229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Four fluorescence polarization immunoassays for therapeutic drug monitoring evaluated.
    Haver VM; Audino N; Burris S; Nelson M
    Clin Chem; 1989 Jan; 35(1):138-40. PubMed ID: 2463117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative thin-layer chromatographic method for the determination of procainamide and its major metabolite in plasma.
    Wesley-Hadzija B; Mattocks AM
    J Chromatogr; 1977 May; 143(3):307-13. PubMed ID: 863987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations.
    Bauer LA; Black D; Gensler A; Sprinkle J
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):213-6. PubMed ID: 2472362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Theophylline, dyphylline, caffeine, acetaminophen, salicylate, acetylsalicylate, procainamide, and N-acetylprocainamide determined in serum with a single liquid-chromatographic assay.
    Ou CN; Frawley VL
    Clin Chem; 1982 Oct; 28(10):2157-60. PubMed ID: 6181911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiarrhythmic potency of N-acetylprocainamide.
    Elson J; Strong JM; Lee WK; Atkinson AJ
    Clin Pharmacol Ther; 1975 Feb; 17(2):134-40. PubMed ID: 1122675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Age-related pharmacokinetics of N-acetylprocainamide in rats.
    Yacobi A; Kamath BL; Stampfli HF; Look ZM; Lai CM
    J Pharm Sci; 1983 Jul; 72(7):789-92. PubMed ID: 6193264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic study.
    Lessard E; Fortin A; Coquet A; Bélanger PM; Hamelin BA; Turgeon J
    J Chromatogr Sci; 1998 Jan; 36(1):49-54. PubMed ID: 9443381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GLC determination of procainamide in biological fluids.
    Simons KJ; Levy RH
    J Pharm Sci; 1975 Dec; 64(12):1967-70. PubMed ID: 1206490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemoperfusion for treatment of N-acetylprocainamide intoxication.
    Braden GL; Fitzgibbons JP; Germain MJ; Ledewitz HM
    Ann Intern Med; 1986 Jul; 105(1):64-5. PubMed ID: 2424355
    [No Abstract]   [Full Text] [Related]  

  • 51. Disposition of procainamide and N-acetylprocainamide in protein-calorie malnutrition.
    Jung D; Nanavaty M; Prasad P
    Drug Metab Dispos; 1985; 13(3):359-63. PubMed ID: 2410212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Verification of therapeutic levels of procainamide and N-acetyl- procainamide in ventricular arrhythmia].
    Sinkiewicz W; Marzec A; Jankowski A; Hoffmann A; Makuch K; Romański B
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):458-60. PubMed ID: 1703654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide.
    Lahita R; Kluger J; Drayer DE; Koffler D; Reidenberg MM
    N Engl J Med; 1979 Dec; 301(25):1382-5. PubMed ID: 91972
    [No Abstract]   [Full Text] [Related]  

  • 54. Reversed-phase liquid chromatography method for measurement of procainamide and three metabolites in serum and urine: percent of dose excreted as deethyl metabolites.
    Coyle JD; MacKichan JJ; Boudoulas H; Lima JJ
    J Pharm Sci; 1987 May; 76(5):402-5. PubMed ID: 2443639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid determination of procainamide and its N-acetyl derivative in human plasma by high-pressure liquid chromatography.
    Weddle OH; Mason WD
    J Pharm Sci; 1977 Jun; 66(6):874-5. PubMed ID: 874793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trimethoprim alters the disposition of procainamide and N-acetylprocainamide.
    Kosoglou T; Rocci ML; Vlasses PH
    Clin Pharmacol Ther; 1988 Oct; 44(4):467-77. PubMed ID: 2458879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-acetylprocainamide's antiarrhythmic action in patients with ventricular tachycardia.
    Somberg J; Wynn J; Miura D; Torres V; Williams S; Keefe D
    Angiology; 1986 Dec; 37(12 Pt 2):972-81. PubMed ID: 2433972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue distribution of N-acetylprocainamide in rats.
    Yacobi A; Stampfli HF; Lai CM; Kamath BL
    Drug Metab Dispos; 1981; 9(3):193-5. PubMed ID: 6166443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A new anti-arrhythmia drug. II. Comparative studies of the effects of a new acyl derivative of procainamide, procainamide and N-acetylprocainamide on blood pressure and the electrocardiogram in rabbits].
    Kusowska J
    Acta Pol Pharm; 1989; 46(1):90-7. PubMed ID: 2479226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procainamide and N-acetylprocainamide kinetics investigated simultaneously with stable isotope methodology.
    Dutcher JS; Strong JM; Lucas SV; Lee WK; Atkinson AJ
    Clin Pharmacol Ther; 1977 Oct; 22(4):447-57. PubMed ID: 902457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.